Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
Symbol NR2F2 contributors: mct/npt - updated : 25-09-2015
HGNC name nuclear receptor subfamily 2, group F, member 2
HGNC id 7976
  • a N terminal modulating domain
  • a central bipartite zinc finger, DNA binding domain
  • a C terminal ligand domain, strongly repressing NTS transcription, whereas the N-terminal domain antagonizes this repressive effect (MID: 21030593)
  • mono polymer homomer , dimer
    interspecies ortholog to rattus Nr2f2
    ortholog to murine Nr2f2
    homolog to C. elegans unc-55
  • small family of the steroid/thyroid hormone receptor nuclear superfamily of transcription factors
  • NR2 subfamily
  • CATEGORY regulatory , receptor nuclear membrane serine/threonine
    SUBCELLULAR LOCALIZATION     intracellular
    basic FUNCTION
  • may be required for angiogenesis and heart developpment
  • negative post transcriptional regulator of MYOD1 function
  • involved in the regulation of the apolipoprotein A-I gene transcription
  • playing a critical role in repressing Notch signaling to maintain vein identity
  • having an important maternal function in placental formation and involved in trophoblast giant cells differentiation
  • plays important roles in the regulation of the function of PROX1, and regulates the functions of PROX1 in lymphatic endothelial cells through direct interaction (Yamazaki 2009)
  • functions as a coregulator of PROX1 to control several lineage-specific genes including FLT4, FGFR3, and NRP1 and is required along with PROX1 to maintain lymphatic endothelial cells phenotype (Lee 2009)
  • directly regulates the transcription of angiopoietin-1 in pericytes to enhance neoangiogenesis (Qin 2010)
  • controls angiopoietin-1/Tie2 signaling to regulate tumor angiogenesis (Qin 2010)
  • important for both initiation and continued expansion and maintenance of angiogenic process (Qin 2010)
  • with NR2F1 play roles in amacrine cell differentiation (Inoue 2010)
  • involved in the organogenesis of the stomach, limbs, skeletal muscles, and heart
  • is required for the specification of the metanephric mesenchyme
  • plays a central role in the specification of metanephric fate and in the maintenance of metanephric mesenchyme proliferation and survival by acting as a crucial regulator of EYA1 and WT1 expression
  • pleiotropic developmental transcription factor
  • play a key role in integrating genetic and environmental risk factors for abnormal cardiac development
  • is a human "pro-ovary" and "anti-testis" sex-determining factor in female gonads
  • may be required to establish ovary identity during early human gonad development by the repression of genes involved in testis determination
  • acts both positively and negatively to modulate the expression of genes involved in sex determination in other cellular and organ contexts
  • CELLULAR PROCESS nucleotide, transcription, regulation
    metabolism lipid/lipoprotein
    signaling signal transduction
    a component
    DNA binding to DNA site A
    small molecule metal binding,
  • Zn2+
  • protein
  • functions as a transcriptional repressor of pro-testis genes
  • directly regulates the expression of both EYA1 and WT1 in the metanephric mesenchyme
  • interacts with SMAD4 to modulate TGFB1 signalling
  • FGF2 is an extracellular inducer of NR2F2 expression and may suppress the osteogenic potential of mesenchymal cells by inducing NR2F2 expression prior to the onset of osteogenic differentiation
  • cell & other
    corresponding disease(s) DEL15QD , DIH1 , VCHD
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --low  
    significantly impaired adult neoangiogenesis (Qin 2010)
    tumoral       gain of function
    upregulated in metastatic prostate cancer, and its higher expression correlated with a worse clinical outcome
    Susceptibility to nonsyndromic atrioventricular septal defects (AVSDs)
    Variant & Polymorphism other
  • variants in NR2F2 probably contribute to AVSDs and other CHDs during human development
  • Candidate gene for heart defects in del 15q patients
    for isolated congenital diaphragmatic hernia
    Therapy target
    inhibition of NR2F2 may offer a therapeutic approach for anticancer intervention
    . inhibition of NR2F2 suppresses metastases of mammary tumors to the lung
    is a potential drug target for the intervention of metastatic human prostate cancer
  • decreased dosage of Nr2f2 in mice has been shown to result in abnormal development of atrioventricular septa
  • mice lacking Coup-tf2 die around E10 due to defects of angiogenesis and heart development